CURRENT INVESTORS
CONTACT US
The US unsustainably spends $4.5T on healthcare annually, representing 17.3% of GDP.
Government influences the vast majority of healthcare spend and policy changes are a key driver of innovation.
Early-stage innovators adapt quickly and benefit from these regulatory incentives and tailwinds.
Dissimilar to conventional venture approaches, we identify young companies and players in markets that have potential for accelerated growth due to government action.
With backgrounds that include investing experience, government acumen, and operational expertise, we are uniquely positioned to select companies building
on favorable US regulatory tailwinds,
sourced globally.